L－NNA及NO供体对延髓腹外侧头端区神经元自发放电的影响

在麻醉大鼠观察了静注ＮＯ合成酶抑制剂Ｎ－硝基左旋精氨酸（Ｌ－ＮＮＡ）和ＮＯ供体──硝普钠（ＳＮＰ）和ＳＩＮ－Ｉ对血压、心率和延髓腹外侧头端区（ＲＶＬＭ）神经元自发放电活动的影响,旨在探讨Ｌ－ａｒｇ：ＮＯ通路对动脉血压调节的中枢作用部位。所得结果如下：（１）静注Ｌ－ＮＮＡ后,平均动脉压（ＭＡＰ）升高,心率（ＨＲ）加快,１１个ＲＶＬＭ神经元自发放电频率增加。这些变化发生于给药后５ｍｉｎ,持续时间达３０ｍｉｎ以上。（２）静注ＳＮＰ后,ＭＡＰ降低,ＨＲ加快,２３个ＲＶＬＭ神经元自发放电频率降低,且有剂量依赖性。ＳＮＰ作用发生快,持续时间短。为了排除脑缺血的影响,还特意向一侧颈动脉内注射相同剂量ＳＮＰ,结果引起ＭＡＰ轻度降低,而ＨＲ无明显改变,但ＲＶＬＭ神经元自发放电频率仍显著降低。（３）静注另一ＮＯ供体ＳＩＮ－Ｉ后,ＭＡＰ降低,１１个ＲＶＬＭ神经元自发放电频率降低．与ＳＮＰ的效应基本一致。以上结果提示,ＲＶＬＭ是Ｌ－ａｒｇ：ＮＯ通路实现动脉血压调节的一个中枢作用部位。     

头端延髓腹外侧区血管加压素在刺激中脑dPAG区诱发防御性升压反应中的…

雄性Ｓｐｒａｇｕｅ－Ｄａｗｌｅｙ大鼠,用乌拉坦（７００ｍｇ／ｋｇ）和氯醛糖（３０ｍｇ／ｋｇ）腹腔麻醉。在双侧头端延髓腹外侧区（ｒＶＬＭ区）每侧微量注射血管加压素（ＡＶＰ）（１０ｐｍｏｌ／０．１μｌ）可引起平均动脉压（ＭＢＰ）升高,心率（ＨＲ）变化不明显,每侧微量注射ＡＶＰ的Ｖ１受体拮抗剂ｄ（ＣＨ２）５［Ｔｙｒ（Ｍｅ）＾２］ＡＶＰ（０．１ｎｍｏｌ／０．１μｌ）后ＭＢＰ和ＨＲ无明显变化。若预先在ｒＶＬ     

延髓头端腹外侧区血管升压素能机制在应激性高血粘度中的作用

观察延髓头端腹外侧区（ｒＶＬＭ）微量注射血管升压素（ＡＶＰ）能否影响正常大鼠的血压和血粘度,并分析ｒＶＬＭ内ＡＶＰ能机制在清醒大鼠经悬吊加束缚引起应激性升压反应和高血粘度中的影响。结果如下：⑴正常大鼠双侧ｒＶＬＭ微量注射ＡＶＰ（每侧０．５μｇ／０．５μｌ）,可引起血压和血粘度升高;此作用可被事先在同一位置微量注射ＡＶＰ－Ｖ１受体拮抗剂ｄ（ＣＨ２）５「Ｔｙｒ（Ｍｅ）＾２」ＡＶＰ（每侧０．１μｇ／０．     

P物质在谷氨酸兴奋外侧下丘脑-穹窿周围区引起的升压反应中之作用

Ｐ物质（ＳＰ）能神经元及其轴突末梢和受体广泛分布于很多心血管中枢。外侧下丘脑含ＳＰ能神经元,外侧下丘脑投射的升压区内又存在ＳＰ能纤维及ＳＰ受体;因此本工作检验ＳＰ在外侧下丘脑升压反应中的作用。实验显示：（１）Ｌ－谷氨酸（Ｇｌｕ）兴奋外侧下丘脑的穹窿周围区（ＬＨ／ＰＦ）或将ＳＰ分别注入各ＬＨ投射区：蓝斑（ＬＣ）、臂旁核（ＮＰＢ）或中脑导水管周围灰质（ＰＡＧ）均引起升压反应;（２）［Ｄ－Ｐｒｏ２,Ｄ－Ｐｈｅ７,Ｄ－Ｔｒｐ９］－ＳＰ（ＳＰ拮抗剂）预先注入ＬＣ或ＰＡＧ可使Ｇｌｕ兴奋ＬＨ／ＰＦ引起的升压反应减小,而注入ＮＰＢ对该反应无明显影响;（３）双侧延髓头端腹外侧区（ＲＶＬ）分别用酚妥拉明、心得安或阿托品预处理也可明显削弱该反应。结合我们以往的实验结果：ＲＶＬ内的α－、β－、Ｍ－受体介导ＬＣ升压反应,α－和β－受体介导ＰＡＧ－升压反应;本工作显示ＬＨ／ＰＦ可通过其ＳＰ能投射纤维作用于ＬＣ－ＲＶＬ和ＰＡＧ－ＲＶＬ升压系统而实现其升压反应。     

乙酰胆碱对大鼠头端延髓腹外侧区前交感神经元放电的作用

实验采用细胞外记录和微电泳等电生理方法,研究乙酰胆碱（ＡＣｈ）对氨基甲酸乙酯麻醉的大鼠头端延髓腹外侧区（ＲＶＬＭ）前交感神经元放电频率的影响。在ＲＶＬＭ共记录到３５个前交感神经元,微电泳ＡＣｈ能增加其放电（Ｐ〈０．０５）,并且具有剂量依赖性。其中２２个神经元微电泳Ｍ型胆碱受体阻断剂阿托品（ＡＴＲ）后能明显降低前交感神经元的基础放电（Ｐ〈０．０５）和完全阻断ＡＣｈ引起的神经元兴奋作用;分别向其余７和     

延髓头端腹外侧区肾上腺素能机制在应激性升压反应和心动过速中的作用

目的和方法：在延髓头端腹外侧区（ｒＶＬＭ）内注射肾上腺素（Ｅ）旨在能否影响正常大鼠的血压和心率,并分析ｒＶＬＭ内肾上腺素能机制在应激性升压反应和心动过速中的作用。将清醒ＳＤ大鼠四肢固定在铁丝网架上,经束缚方法观察应激性血压和心率的变化。结果：①束缚清醒大鼠可引起升压反应和心动过速;②在双侧ｒＶＬＭ内注射微量Ｅ可引起血压和心率垢明显增加,此作用可被在同一区域双侧注射α－肾上腺素能受体阻断剂（酚妥拉明     

延髓头端腹外侧区注入肾上腺素对血液流变学的影响

实验用ＳＤ雄性大鼠７８只,采用束缚方法引起应激性高血粘度和血压升高。结果：（１）清醒大鼠束缚２ｄ可引起应激性高血粘度和血压升高。（２）双侧延髓头端腹外侧区（ｒＶＬＭ）微量注射肾上腺素（Ｅ,每侧０．５μｇ／０．５μｌ）可引起血粘度明显增高,此作用可预先在双侧ｒＶＬＭ注入α肾上腺素能受体阻断剂酚妥拉明所阻断,不能被β－肾上腺能受体阻断剂心得安所阻断。用同样剂量Ｅ注入双侧延髓尾端腹外侧区（ｃＶＬＭ）或静     

纳洛酮在延髓腹外侧加压区加强P物质引起的升压效应

目的：探讨Ｐ物质（ＳＰ）在延髓腹外侧加压区（ＶＳＭｐ）的升压效应是否与内源性阿片样物质有关。方法：氨基甲酸乙酯麻醉、人工呼吸,暴露延髓腹侧面,ＶＳＭｐ 敷贴ＳＰ等药物。结果：ＶＳＭｐ 敷贴ＳＰ可使血压呈剂量效应关系的明显增高,但心率无明显变化;在ＶＳＭｐ 给纳洛酮进行预处理,可显著增强ＳＰ的升压效应;应用神经元细胞体兴奋剂Ｌ谷氨酸钠到ＶＳＭｐ 可使血压显著升高。结论：ＳＰ 在ＶＳＭｐ 具有明显的升压作用,内源性阿片样物质在ＶＳＭｐ 对ＳＰ升压效应起拮抗作用,ＳＰ的升压效应可能是兴奋ＶＳＭｐ 的神经元细胞体实现的     

内皮素通过最后区易化大鼠延髓腹外侧头端区神经元活动

在３５只切断双侧缓冲神经、用氨基甲酸乙酯－α氯醛糖混合麻醉的Ｓｐｒａｇｕｅ－Ｄａｗｌｅｙ大鼠,应用细胞外记录的电生理学方法,由ＲＭ－６０００型多道生理记录仪和ＷＳ－６８２Ｇ热阵记录器（频响范围０～２．８ｋＨｚ）同步记录血压、心率和单位神经元放电,观察颈动脉注射内皮素对８７个延髓腹是头端区（ＲＶＬＭ）自发放电神经元活动的影响,所得结果如下;（１）颈动脉注射ＥＴ－１（０．３ｎｍｏｌ／ｋｇ）时３６个单位     

硝基左旋精氨酸对睡眠抑制作用的机制研究

本文观察了硝基左旋精氨酸（Ｌ－ＮＮＡ,５０ｍｇ／ｋｇ,ｉｐ）和Ｌ－精氨酸（Ｌ－ａｒｇ,１１０ｍｇ／ｋｇ,ｉｐ）对慢性植入电极的大鼠睡眠－觉醒周期的影响及中缝核５－羟色胺（５－ＨＴ）神经元免疫阳性反应的变化。结果表明：Ｌ－ＮＮＡ显著抑制慢波睡眠和快眼动睡眠,使平均动脉压（ＭＡＰ）升高。Ｌ－ａｒｇ则使ＭＡＰ显著降低,对睡眠无明显影响。预先给予Ｌ－ａｒｇ可逆转Ｌ－ＮＮＡ的效应。腹腔给予Ｌ－ＮＮＡ后２ｈ,     

延髓腹外侧头端区注射肾上腺髓质素对大鼠血压、心率和肾交感神经活动的影响

本研究在 3 4只麻醉Sprague Dawley大鼠观察了延髓腹外侧头端区内微量注射肾上腺髓质素 ( 10μmol/L ,2 0 0nl)对平均动脉压 (MAP)、心率 (HR)和肾交感神经放电 (RSNA)的影响。实验结果如下 :( 1)延髓腹外侧头端区内微量注射肾上腺髓质素可引起MAP、HR、和RSNA明显增加 ,分别由 99 0 9± 3 3 2mmHg ,3 70 78± 7 84bpm和 10 0± 0 %增至 113 5 7± 3 64mmHg (P <0 0 0 1) ,3 83 2 8± 7 3 8bpm (P <0 0 0 1)和 12 3 72±2 74% (P <0 0 0 1) ;( 2 )降钙素基因相关肽受体阻断剂CGRP8 3 7( 10 0 μmol/L ,2 0 0nl)不能阻断肾上腺髓质素的上述效应 ;( 3 )静脉注射NO前体L 精氨酸 ( 10 0mg/kg ,0 2ml)可消除肾上腺髓质素的上述效应。以上结果提示 ,肾上腺髓质素作用于延髓腹外侧头端区可产生显著的心血管作用 ,此作用不是由降钙素基因相关肽受体介导 ,但可被NO所阻断     

Increased GABA(A) inhibition of the RVLM after hindlimb unloading in rats

Attenuated baroreflex-mediated increases in renal sympathetic nerve activity (RSNA) in hindlimb unloaded (HU) rats apparently are due to changes within the central nervous system. We hypothesized that GABA(A) receptor-mediated inhibition of the rostral ventrolateral medulla (RVLM) is increased after hindlimb unloading. Responses to bilateral microinjection of the GABA(A) antagonist (-)-bicuculline methiodide (BIC) into the RVLM were examined before and during caudal ventrolateral medulla (CVLM) inhibition in Inactin-anesthetized control and HU rats. Increases in mean arterial pressure (MAP), heart rate (HR), and RSNA in response to BIC in the RVLM were significantly enhanced in HU rats. Responses to bilateral CVLM blockade were not different. When remaining GABA(A) inhibition in the RVLM was blocked by BIC during CVLM inhibition, the additional increases in MAP and RSNA were significantly greater in HU rats. These data indicate that GABA(A) receptor-mediated inhibition of RVLM neurons is augmented after hindlimb unloading. Effects of input from the CVLM were unaltered. Thus, after cardiovascular deconditioning in rodents, the attenuated increase in sympathetic nerve activity in response to hypotension is associated with greater GABA(A) receptor-mediated inhibition of RVLM neurons originating at least in part from sources other than the CVLM.     

Contribution to sympathetic vasomotor tone of tonic glutamatergic inputs to neurons in the RVLM

The role of excitatory amino acid (EAA) receptors in the rostral ventrolateral medulla (RVLM) in maintaining resting sympathetic vasomotor tone remains unclear. It has been proposed that EAA receptors in the RVLM mediate excitatory inputs both to presympathetic neurons and to interneurons in the caudal ventrolateral medulla (CVLM), which then provide a counterbalancing inhibition of RVLM presympathetic neurons. In this study, we tested this hypothesis by determining the effect of blockade of EAA receptors in the RVLM on mean arterial pressure (MAP), heart rate (HR), and renal sympathetic nerve activity (RSNA), after inhibition of CVLM neurons. In anesthetized rats, bilateral injections of muscimol in the CVLM increased MAP, HR, and RSNA. Subsequent bilateral injections of kynurenic acid (Kyn, 2.7 nmol) in the RVLM caused a modest reduction of approximately 20 mmHg in the MAP but had no effect, when compared with the effect of vehicle injection alone, on HR or RSNA. By approximately 50 min after the injections of Kyn or vehicle in the RVLM, the MAP had stabilized at a level close to its original baseline level, but the HR and RSNA stabilized at levels above baseline. The results indicate that removal of tonic EAA drive to RVLM neurons has little effect on the tonic activity of RVLM presympathetic neurons, even when inputs from the CVLM are blocked. Thus the tonic activity of RVLM presympathetic neurons under these conditions is dependent on excitatory synaptic inputs mediated by non-EAA receptors and/or the autoactivity of these neurons.     

延髓头端腹外侧区一氧化氮与慢性心力衰竭大鼠心交感传入反射物的关系

为观察延髓头端腹外侧区(rostral ventrolateral medulla,RVLM)一氧化氮(N0)在慢性心力衰竭(chronic heart failure,CHF)大鼠增强的心交感传入反射(cardiac sympathetic afferent reflex,CSAR)中的作用,实验在去压力感受器神经支配的结扎冠状动脉诱发的CHF大鼠和假手术SD大鼠进行,记录电刺激心交感传入神经中枢端前后的血压和肾交感神经活动(renal sympathetic nerve activity,RSNA)变化以评价CSAR。结果显示：(1)CHF大鼠的CSAR显著增强;(2)RVLM微量注射NO合酶(NOS)抑制剂MeTC增强对照组大鼠的CSAR但对CHF大鼠的CSAR无显著影响;(3)RVLM微量注射NO供体S-nitroso-N-acetyl-penicillamine(SNAP)抑制CHF大鼠增强的CSAR;(4)S-methyl-L-thioeitruline（MeTC)仅增强对照组大鼠基础水平的RSNA,而SNAP抑制对照组和CHF大鼠基础水平的RSNA。结果表明RVLM中内源性NO的减少是导致CHF大鼠CSAR增强的重要机制之一。     

延髓头端腹外侧区一氧化氮与慢性心力衰竭大鼠心交感传入反射的关系

为观察延髓头端腹外侧区(rostral ventrolateral medulla,RVLM)一氧化氮(NO)在慢性心力衰竭(chronic heartfailure,CHF)大鼠增强的心交感传入反射(cardiac sympathetic afferent reflex,CSAR)中的作用,实验在去压力感受器神经支配的结扎冠状动脉诱发的CHF大鼠和假手术SD大鼠进行,记录电刺激心交感传入神经中枢端前后的血压和肾交感神经活动(renal sympathetic nerve activity,RSNA)变化以评价CSAR.结果显示:(1)CHF大鼠的CSAR显著增强;(2)RVLM微量注射NO合酶(NOS)抑制剂MeTC增强对照组大鼠的CSAR但对CHF大鼠的CSAR无显著影响;(3)RVLM微量注射NO供体S-nitroso-N-acetyl-penicillamine(SNAP)抑制CHF大鼠增强的CSAR;(4)S-methyl-L-thiocitmline(MeTC)仅增强对照组大鼠基础水平的RSNA,而SNAP抑制对照组和CHF大鼠基础水平的RSNA.结果表明RVLM中内源性NO的减少是导致CHF大鼠CSAR增强的重要机制之.     

失血引起兔肾神经和肾上腺交感神经活动的变化

本文观察了急性失血引起的戊巴比妥钠麻醉兔的肾交感神经活动(RSNA)和肾上腺交感神经活动(AdSNA)的变化。股动脉放血,在10min内使平均动脉压(MAP)下降至5.3kPa。失血过程中RSNA先兴奋后抑制,AdSNA则一直呈兴奋反应,这反应可由动脉压力感受器去神经而消失。失血前和失血后切断迷走神经均可翻转失血引起的RSNA抑制,但不能阻断AdSNA的兴奋反应。静脉注射纳洛酮和延髓腹外侧头端(RVLM)微量注射纳洛酮可翻转失血引起的RSNA抑制,但对AdSNA兴奋反应无显著影响。失血引起心率(HR)和RSNA一样,但不能为纳洛酮所反转。上述结果表明:失血引起的RSNA抑制是由迷走神经传入纤维和阿片肽(尤其是RVLM中的阿片肽)参与所致,而AdSNA的兴奋则与动脉压力感受器传入纤维有关。     

Differential cardiorespiratory control elicited by activation of ventral medullary sites in mice.

We studied the respiratory and blood pressure responses to chemical stimulation of two regions of the ventral brainstem in mice: the rostral and caudal ventrolateral medulla (RVLM and CVLM, respectively). Stimulation of the RVLM by microinjections of the excitatory amino acid L-glutamate induced increases in diaphragm activity and breathing frequency, elevation of blood pressure (BP), and a slight increase in heart rate (HR). However, activation of the CVLM induced a decrease in breathing frequency, mainly due to prolongation of expiratory time (TE), and hypotension associated with a slight slowing of HR. Because adrenergic mechanisms are known to participate in the control of respiratory timing, we examined the role of alpha(2)-adrenergic receptors in the RVLM region in mediating these inhibitory effects. The findings demonstrated that blockade of the alpha(2)-adrenergic receptors within the RVLM by prior microinjection of SKF-86466 (an alpha(2)-adrenergic receptor blocker) significantly reduced changes in TE induced by CVLM stimulation but had little effect on BP responses. These results indicate that, in mice, activation of the RVLM increases respiratory drive associated with an elevation of BP, but stimulation of CVLM induces prolongation of TE via an alpha(2)-adrenergic signal transduction pathway.     

延髓腹外侧一氧化氮介导电针内关对急性心肌缺血大鼠心功能的作用

实验在以乌拉坦和氯醛糖混合麻醉的雄性SD大鼠上进行。结扎左冠状动脉前降支以建立急性心肌缺血(AMI)动物模型。病理学检查显示该模型具有典型的心肌缺血改变。功能学改变包括心率(HR)减慢、平均动脉压(MAP)降低,以及心功能减弱,如左室舒张末压(LVEDP)增大,左室收缩压(LVSP)、左室压变化最大速率(±dp/dt)、左室收缩成分缩短速度(VCE)、心力环总面积(L0)等均明显减小。电针AMI大鼠的内关穴位20 min,可使其HR、MAP、LVEDP、LVSP、±dp/dt、VCE和L0等均明显改善。若电针前于延髓头端腹外侧区(RVLM)微量注射一氧化氮合酶(NOS)抑制剂L-NNA(0.1 mmol/L,0.1 μl),除HR和MAP外,电针改善AMI心功能的其余各项指标均减弱或被取消,而以等量的生理盐水取代L-NNA被注入RVLM时,则不能影响EA对AMI各项心功能指标的改善作用。以上结果提示电针内关改善AMI的作用由RVLM的一氧化氮(NO)所介导。     

Sympathoinhibitory pathway from caudal midline medulla to RVLM is independent of baroreceptor reflex pathway

Glutamate stimulation of the caudal midline medulla (CMM) causes profound sympathoinhibition due to GABAergic inhibition of presympathetic neurons in the rostral ventrolateral medulla (RVLM). We investigated whether the sympathoinhibitory pathway from CMM to RVLM, like the central baroreceptor reflex pathway, includes a glutamatergic synapse in the caudal ventrolateral medulla (CVLM). In pentobarbital sodium-anesthetized rats, the RVLM on one side was inhibited by a muscimol microinjection. Then the response evoked by glutamate microinjections into the CMM or by baroreceptor stimulation was determined before and after 1) microinjection of the GABA receptor antagonist bicuculline into the RVLM on the other side or 2) microinjections of the glutamate receptor antagonist kynurenate bilaterally into the CVLM. Bicuculline in the RVLM greatly reduced both CMM- and baroreceptor-evoked sympathoinhibition. Compared with the effect of vehicle solution, kynurenate in the CVLM greatly reduced baroreceptor-evoked sympathoinhibition, whereas its effect on CMM-evoked sympathoinhibition was not different from that of the vehicle solution. These findings indicate that the output pathway from CMM sympathoinhibitory neurons, unlike the baroreceptor and other reflex sympathoinhibitory pathways, does not include a glutamatergic synapse in the CVLM.     

Nitric oxide at the CVLM is involved in the attenuation of the reflex bradycardia in renovascular hypertensive rats

Hypertension is associated to an increase in central oxidative stress and an attenuation of the baroreflex control of arterial pressure. The present study evaluated the effect of alterations in the levels of nitric oxide (NO) and superoxide anion in the caudal ventrolateral medulla (CVLM), a key area of the brainstem for the baroreflex control of arterial pressure, in renovascular hypertensive rats (2K1C). Baseline mean arterial pressure (MAP), heart rate (HR), and reflex bradycardia were evaluated 30 days after renal artery occlusion in anesthetized (urethane, 1.2 g/kg, i.p.) 2K1C or normotensive (SHAM) rats. The MAP, HR, and baroreflex control of HR were evaluated before and after CVLM microinjections of the non-selective NOS inhibitor L-NAME (10 nmol), the NO precursor L-ARG (50 nmol), or the antioxidant ascorbic acid, Vit C (10 nmol). In both 2K1C and SHAM animals, CVLM microinjection of L-NAME produced a decrease in MAP, whereas L-ARG induced a significant increase in MAP. However, microinjection of Vit C into the CVLM produced a decrease in MAP and HR only in 2K1C and not in SHAM rats. Cardiovascular effects produced by microinjection of l-ARG into the CVLM were abolished by prior microinjection of L-NAME in the CVLM of 2K1C and SHAM rats. Microinjection of L-NAME into the CVLM increased the sensitivity of reflex bradycardia in 2K1C animals. In contrast, the CVLM microinjection of L-ARG reduced reflex bradycardia only in SHAM rats. Vit C in the CVLM did not change reflex bradycardia in either 2K1C or in SHAM rats. These results suggest that increased oxidative stress in the CVLM during hypertension contributes to the reduced baroreflex sensitivity and to maintain hypertension in the 2K1C model.